A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer

BACKGROUND: A key priority in developing policies for providing affordable cancer care is measuring the value for money of new therapies using cost-effectiveness analyses (CEAs). For CEA to be useful it should focus on relevant outcomes and include thorough investigation of uncertainty. Randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: John-Baptiste, Ava A., Wu, Wei, Rochon, Paula, Anderson, Geoffrey M., Bell, Chaim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646035/
https://www.ncbi.nlm.nih.gov/pubmed/23671612
http://dx.doi.org/10.1371/journal.pone.0062614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646035/
https://www.ncbi.nlm.nih.gov/pubmed/23671612
http://dx.doi.org/10.1371/journal.pone.0062614

Ejemplares similares